Porton Pharma Solutions Ltd. | 领英 (original) (raw)
``
关于我们
Founded in 2005, Porton Pharma Solutions Ltd. is an internationally recognized pharmaceutical contract development and manufacturing organization (CDMO) in enabling our global clients to optimize drug development and manufacturing. We provide customer development and manufacturing services for small molecule, Large molecule and Gene and Cell Therapies from pre-clinical to commercialization. As of June 30, 2023, we have a proven record for the delivery of more than 2600 projects and established cooperation with more than 800 global clients. With our 5000+ skilled employees working across 20+ sites around the globe, Porton is committed to becoming the most open, innovative and reliable pharmaceutical service platform in the world and enabling the public’s early access to good medicines. Porton is publicly listed on the Shenzhen Stock Exchange (Ticker: 300363). With over 5000 customer-centric employees, operations and commercial offices across the US, EU and China, Porton Pharma Solutions/J-Star Research provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and GMP manufacturing services across small molecule APIs, TIDES, biologics and Gene & Cell Therapies. We focus on the customer and have been recognized through awards by industry forums and global pharmaceutical companies for our process innovation, supply chain performance, and compliance with global Quality and EHS standards. We constantly strive for excellence and enable the public’s early access to good medicines.
所属行业
制药业
规模
5,001-10,000 人
总部
Beibei，Chongqing
类型
上市公司
创立
2005
地点
- 主要
Fangzheng Ave.
CN，Chongqing，Beibei，4000714
获取路线 - Hadley Rd
US，New Jersey，South Plainfield，07080
获取路线 - US，New Jersey，Cranbury，08512
获取路线 - SI，Menges
获取路线 - DK，Copenhagen
获取路线 - CH，Root
获取路线 - CN，Shanghai
获取路线 - CN，Yichun
获取路线 - CN，Suzhou
获取路线 - BE，Turnhout
获取路线
Porton Pharma Solutions Ltd.员工
动态
- Highly Potent Active Pharmaceutical Ingredients (#HPAPI) and Potent compounds are playing an ever-increasing role in pharmaceutical development due to their potential to induce potent biological effects even at minimal doses. Porton Pharma Solutions Ltd. & Porton J-STAR Research, Inc. sets a new standard in this capacity, recognizing the need for rigorous handling and containment controls to safely process these materials. Our state-of-the-art 3000 sq ft facility, equipped with multiple isolated glovebox workstations capable of achieving containment levels of less than 30 ng/m³, is designed for optimized development and #manufacturingHPAPI, Antibody-Drug Conjugates (ADCs), and other potent compounds. We provide both non-GMP and cGMP services tailored to your specific needs. Porton Pharma Solutions Ltd. & J-STAR Research, Inc. is committed to providing top-tier #development and manufacturing solutions, ensuring safety and compliance. Reach out to our team at business@portonusa.com to discuss your HPAPI and Potent Compound needs today. Hope your day is packed with positivity.#follow us here https://lnkd.in/d64pQsdB #HPAPI #HPAPITrends #ADC #SpecialityChemicals #customerfocus #cmc #cdmo #healthcare #api
- In this autumn season, Porton Pharma Solutions Ltd. Color Day is like a dazzling rainbow rain, gently showering upon us and enlivening every ordinary day. From the urban oasis of Shanghai to the picturesque lakeside of Chongqing, and further to the warm and welcoming factory premises in Yichun, Jiangxi, and Xiaogan, Hubei... This party, which blends vitality, laughter, and delicious food, not only makes us feel life's infinite possibilities but also fills us with anticipation and longing for the future. Hope your day is packed with positivity.#follow us here https://lnkd.in/d64pQsdB #contactus ☑ : https://lnkd.in/ew62rcqe #wecare #healthcare #teamwork #future #customerfocus #colorday
- ✨Visit Porton J-Star✨ We cordially invite you to tour our facilities for integrated DS-DP, GMP DP, and new GMP HPAPI suites at Porton J-STAR Research, Inc. in Cranbury, New Jersey. These facilities house cutting-edge services in HPAPI and High Potent Compound Handling, Solid State Studies, #Crystallization R&D, DS-DP Co-Processing, #Formulation R&D, and Drug Product GMP #Manufacturing. Our technical leaders and teams are available to meet with you to discuss your specific interests. We believe a visit to our site will offer you the chance for #insightful engagement with our scientists, to see firsthand our labs and equipment, and lead to the #opportunity for you to leverage our services on your #pharmaceutical research and #development programs. We invite you to book a tour at your convenience by emailing business@portonusa.com to arrange a suitable time for your visit. NEW in Cranbury: • Qualified OEB 5 (OEL < 0.02 μg/m3) R&D Labs • 5 Drug Product GMP Suites • HPAPI GMP Suite for HPAPI and ADC Payload-Linker Processing#adc #hpapi #gmp #healthcare #drugproduct #drugsubstance #smallmolecules #cmc #cdmo #wecare #pharma
- Porton Pharma Solutions Ltd. and Porton J-STAR Research, Inc., as an industry-leading #CDMO, is dedicated to assisting clients in overcoming #drugformulation and manufacturing challenges where Amorphous Solid Dispersion (ASD) or Spray Dried Dispersion (SDD) can help address your drug #solubility and #bioavailability challenges. Our team led by Dr. Hugh Huang under our CTO, Dr. San Kiang, leverages deep scientific expertise and broad capabilities in spray drying, #characterization of Amorphous Solid Dispersion / Spray Dried Dispersion (SDD), and the development of ASD/SDD strategies for your R&D and GMP #drugproduct development needs. Contact us at business@portonusa.com to see how we support your #molecule. Be sure to watch Episode 3 of our video series, "Co-processing: Porton J-STAR Research, Inc.'s Role in Advancing Pharma's Adoption of New Enabling Technologies," where our expert Yuanhao Yu discusses "ASD - How Co-processing Can Replace Spray Drying."https://lnkd.in/eKQUvwyyHope your day is packed with positivity.#follow us here https://lnkd.in/d64pQsdB #healthcare #pharmaceutical #science #medicine #asd #spraydrying #manufacture #amorphoussoliddispersion #healthcare #cmc #cdmo #coprocessing
- ✨ Breaking News
's New Modality Capacity Upgrade Ceremony Successfully Held On November 7, 2024, the New Modality Capacity Upgrade Ceremony was successfully held in Fengxian, Shanghai, China. Attendees included Mr. Weng Jun, Vice General Manager, of Shanghai Hangzhou Bay Economic & Technological Development Co., Ltd., Mr. Bai Yinchun, COO and Senior Vice President of Porton, Ms. Pi Wei, Vice President and Board Secretary of Porton, Ms. Meng Fan, Deputy General Manager of the Sales & Marketing Center of Porton, and Mr. Xie Lihua, Head of the Synthetic Macromolecules Service Department. Together, they witnessed this significant moment of enhancing the production capacity for new modalities at the Fengxian site. Learn more here: https://lnkd.in/eUDQp7VYDo you know how we can help? Contact us here: https://lnkd.in/ew62rcqe #drugproduct #drugsubstance #smallmolecules #API #manufacture #customerfocus #pharma #biopharma #healthcare #wecare #modality #macromolecules
- ✨ "Welcome to Nik Prebil we're so glad you could make it.” ✨
Senior Consultant for Strategic Communication at Herman & partners | Director of Slovenia Biotech Hills | Former Slovenian MP | Board member of AmCham Young Leaders Club
1 周 已编辑
V tem tednu sem v okviru vladno-gospodarske delegacije poslovno v Shanghaju na Kitajskem. Kot direktor zavoda Slovenia Biotech Hills sem sodeloval na investicijski konferenci in potencialnim kitajskim investitorjem predstavil naš edinstven ekosistem ter vizijo na področju razvoja biotehnološko-farmacevtskega sektorja. Včeraj sem obiskal tudi podjetje Porton Pharma Solutions Ltd. Razkazali so mi svoje inovativne prostore za raziskave in razvoj na področju rešitev CDMO za majhne molekule, biološka zdravila in konjugate od predklinične do komercialne faze. Gre za biotehnološko izredno napredno podjetje, ki je z nedavno investicijo v Sloveniji, podoben obrat odprlo tudi v Mengšu. S tem podjetje postaja pomemben partner številnih biotehnoloških in farmacevtskih podjetij iz Slovenije z jasno vizijo vzpostavitve dodatnih razvojnih in drugih kapacitet. V okviru obiska smo obiskali še nekaj izjemno zanimivih in naprednih podjetij na Kitajskem, pri katerih je jasno, da vodijo svetovni tehnološki in tudi avtomobilski razvoj. - 💫Critical Breakthrough💫 The Porton J-STAR Research, Inc. team is excited to share our significant contributions to the development of ENT-03, a promising mammalian analog of trodusquemine for treating #diabetes and #obesity. The asymmetric hydrogenation development was led by Dr. Thorsten R., and published along with several other industry experts including Dr. Hui Chen, Dr. Qi Gao, Dr. Andrew Thompson, and Ian Crouch. A critical #breakthrough in this synthesis involved the asymmetric hydrogenation of an enoic acid, achieving the desired enantiomer with up to 95% enantiomeric excess using only 0.05 mol% of a commercially available ruthenium-Mandyphos catalyst. This success resulted from a meticulous series of high-throughput screening experiments, where we evaluated a variety of #catalysts, #solvents, and #additives across more than 200 reaction conditions. Our rigorous evaluation and #optimization process pinpointed (Me-allyl)2Ru(COD)/SL-M004-1 as the superior #catalyst. We also selected the eco-friendly solvent i-PrOAc, which provided optimal scalability and efficiency in the reaction. The Porton J-STAR Research, Inc. team is dedicated to bringing this level of scientific rigor to all our clients. Contact us at business@portonusa.com to see how we can help your #molecule advance in #development. Schedule a meeting here: https://lnkd.in/eacJ7ebb